RAER Therapeutics

Private

GlasgowHealthcare & Life Scienceshttps://www.raertherapeutics.co.uk/

Last Round

Accelerator

Sep 26, 2025

Company Overview

RAER Therapeutics is a biotechnology company that develops innovative therapies for rare genetic diseases using a rapid, cost-effective screening platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug discoveryrare diseaserobotic screeninghigh-throughput screeningbiotechDrosophila modelsdrug repurposingtherapeutic developmentpre-clinical researchRASopathiesTAUopathiesAdenoid Cystic CarcinomaACCIP licensingin vivo screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RAER Therapeutics Comps

Public and private peers based on sector, stage, and business model.

RAER Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RAER Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 26, 2025

View all Funding Rounds

RAER Therapeutics Investors

Notable investors and investment history

RAER Therapeutics investors
Investor	Rounds
P4 Precision Medicine Accelerator	Accelerator

View all Investors

RAER Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RAER Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RAER Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow

Year Founded2024

Last FundingSep 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.